Heparin-induced thrombocytopenia

  • Mariela Fernández Servicio de Nefrología, Hospital Provincial del Centenario, Rosario
  • Diego Serra Servicio de Nefrología, Hospital Italiano de Buenos Aires, Buenos Aires
  • Luciana Rossi Servicio de Nefrología, Hospital Italiano de Buenos Aires, Buenos Aires
  • Mariela Bedini Rocca Servicio de Nefrología, Hospital Italiano de Buenos Aires, Buenos Aires
  • Angel Medina Ayala Servicio de Nefrología, Hospital Italiano de Buenos Aires, Buenos Aires
  • Soledad Crucelegui Servicio de Nefrología, Hospital Italiano de Buenos Aires, Buenos Aires
  • Salomón Algranati Servicio de Nefrología, Hospital Italiano de Buenos Aires, Buenos Aires
  • Guillermo Rosa Diez Servicio de Nefrología, Hospital Italiano de Buenos Aires, Buenos Aires
Keywords: thrombocytopenia, heparin, thrombosis, anticoagulation, hemodialysis, renal dialysis

Abstract

This is the case of a patient with heparin-induced thrombocytopenia (HIT), a syndrome that can be potentially fatal. Its diagnosis is based on a medical condition compatible with this syndrome and, in addition, with the presence of antibodies.
HIT thromboses can take place one or two days after platelets diminish. Therefore, heparin should be immediately interrupted when HIT is highly suspected. Anticoagulation therapy is the treatment of choice even in the absence of a thrombosis. Fondaparinux can be a useful alternative. HIT can occur without the use of heparin during dialysis in the case of patients with catheters, even if precautions are taken when filling the tubes with the proper amount of heparin. In this case, sodium citrate can avoid a thrombosis if it is used with adequate precaution.

Published
2010-03-01
How to Cite
1.
Fernández M, Serra D, Rossi L, Bedini Rocca M, Medina Ayala A, Crucelegui S, Algranati S, Rosa Diez G. Heparin-induced thrombocytopenia. Rev Nefrol Dial Traspl. [Internet]. 2010Mar.1 [cited 2024Dec.23];30(1):23-8. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/289
Section
Case Report